Therefore, herein, we provided evidence that CD248+CAFs release IL‐8, which augment ABCB1 expression in NSCLC cell to enhance cisplatin resistance in NSCLC (Figure 6J). Here, CD248 is linked to non-small cell lung carcinoma.